{
    "Trade/Device Name(s)": [
        "Immunoglobulin G (IgG)",
        "IgG Reagent"
    ],
    "Submitter Information": "Beckman Coulter Laboratory Systems (Suzhou) Co., Ltd.",
    "510(k) Number": "K221114",
    "Predicate Device Reference 510(k) Number(s)": [
        "K162208"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "February 14, 2023",
    "Summary Letter Received Date": "February 16, 2023",
    "Submission Date": "July 25, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Immunoglobulin G (IgG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter AU480",
        "Beckman Coulter AU680",
        "Beckman Coulter AU5800",
        "Beckman Coulter DxC 500 AU",
        "Beckman Coulter DxC 700 AU"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric"
    ],
    "Methodologies": [
        "Immunoturbidimetric measurement"
    ],
    "Submission Type(s)": [
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter IgG Reagent for quantitative determination of immunoglobulin G in serum, plasma, and cerebrospinal fluid using immunoturbidimetric method on AU/DxC analyzers.",
    "Indications for Use Summary": "System reagent for quantitative determination of IgG immunoglobulins in human serum, plasma, and cerebrospinal fluid on Beckman Coulter AU/DxC AU analyzers to aid in diagnosing abnormal protein metabolism and inability to resist infectious agents.",
    "fda_folder": "Immunology"
}